Cancer has many sites?
I was watching PBS program on genes and apparantly there are many 'sites' that need to be discovered, and then one can target them.
A blood virus etc such as sepsis may have significantly fewer.
If this is the case then it makes sense that CYGX go after these first. Still massive revenue streams from this.
If animal trials are replicable in humans for sepsis....and
our mice trials were an unequivical success. Then what is wrong with what we are seeing in the PPS?
Is there massive dilution going on behind the scenes?
No evidence of that. There seems to be just as many small sellers as buyers...hence price not moving much...albeit
slightly downwards...and remember for this class of stock it doesn't take much to move either way.
My problem is this....
Why no big pharma stampede to our door step?
If co. was in talks with a big pharma....wouldn't Skol tell us?
I'm beginning to wonder if CYGX really has a management team that really knows how to do this.
There is a company here in Houston which sells an implantable device that helps seizures...run by an ex-investment banker...Skip somebody (Cummins)...a bald headed guy.....anyway he took over this company and it went from strength to strength despite many FDA setbacks...stock runs at about $8.(?)
My point is...if anyone has any time, could they look into this.
Maybe we should drop him a line.
An implantable device to aid seizure and depression or cure for sepsis and further down the road when alot of money can be spent.....a cure for cancer?....a no brainer IMO
News 
Market Data 
Discover 
AI
